Deeter Investments’s Immunovant IMVT Stock Holding History

Deeter Investments’s Portfolio IMVT Stock Details IMVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-37,000	Closed	-$919K	–	121
2026 Q1	$919K	Hold	37,000	–	–	0.1%	80
2025 Q4	$941K	Buy	+37,000	New	+$825K	0.2%	60

Other funds holding IMVT

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

Deeter Investments's IMVT Position: Q2 2026 in Review

Deeter Investments sold out of Immunovant (IMVT) in Q2 2026, closing a stake of 37,000 shares — an estimated $919K sold.

Deeter Investments first reported a position in IMVT in Q4 2025 and held it in 2 quarters. The position peaked at $941K in Q4 2025. 226 funds tracked by Wall St. Rank hold IMVT as of Q2 2026.

Deeter Investments reported no remaining Immunovant position as of Q2 2026 after selling out during the quarter.
Deeter Investments sold 37,000 Immunovant shares in Q2 2026, an estimated $919K.
Deeter Investments first reported a position in Immunovant in Q4 2025 and held it in 2 quarters.
Deeter Investments's Immunovant position peaked at $941K in Q4 2025.
226 funds tracked by Wall St. Rank held Immunovant as of Q2 2026.

Based on Deeter Investments's 13F filing for Q2 2026, filed 8 Oct 2026.